NEW YORK, Sept. 25, 2024 /PRNewswire/ — From September 20 to 23, local time, as the only Chinese board member of the UNGC, Zhao Dong, Chairman & Secretary of the Party Committee of Xiamen Airlines, attended the United Nations Global Compact (UNGC) Board Meeting and Secretary-General’s Seminar. During the meeting, Zhao showcased China’s strategic vision and […]
Category Archives: Pr Newswire
MCLEAN, Va., Sept. 25, 2024 /PRNewswire/ — Iridium Communications Inc. (NASDAQ: IRDM), a leading provider of global voice and data satellite communications, today announced that the 3rd Generation Partnership Project (3GPP) accepted Iridium’s request to extend the functionality of Narrowband Internet of Things (NB-IoT) for Non-Terrestrial Networks (NTN) into the Work Plan for 3GPP Release 19 […]
ATLANTA, Sept. 25, 2024 /PRNewswire/ — Sercomm Corporation (TWSE: 5388), a leading global provider of telecom and broadband solutions, announced the launch of its DOCSIS 4.0 Unified Smart Amplifier product portfolio at SCTE® TechExpo 2024. This marks the company’s strategic expansion into its DOCSIS 4.0 Unified Smart Amplifier market, showcasing its commitment to delivering advanced […]
Samsung Biologics showcases new innovative development platforms – S-AfuCHOTM and S-OptiChargeTM – at BioProcess International 2024 New technology platforms to proactively address evolving industry trends and enable high-quality development INCHEON, South Korea, Sept. 25, 2024 /PRNewswire/ — Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), launched today a series of proprietary development […]
HAMILTON, Bermuda, Sept. 25, 2024 /PRNewswire/ — CariGenetics and One BioMed are proud to announce their strategic partnership to bring One BioMed’s Xceler8 Platform across the Caribbean. Implementing this cutting-edge technology in the region marks a major advancement in the field of Caribbean genomic research. One BioMed’s Xceler8 Platform enables more efficient, streamlined high molecular […]
25
Sep
Sep
Direct sales of AlterG products through the Lifeward GmbH sales team expected to improve margins and increase AlterG revenues in Germany, accelerating Lifeward’s path to profitability MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Sept. 24, 2024 (GLOBE NEWSWIRE) — Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to […]
Pr Newswire
Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients
25
Sep
Sep
LOS ANGELES, Sept. 24, 2024 (GLOBE NEWSWIRE) — Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, announces a groundbreaking collaboration with PreCheck Health Services Inc., a CLIA-certified and CAP-accredited clinical laboratory specializing in genetic sequencing. The partnership focuses on the development of companion biomarkers for Kairos Pharma’s cancer therapy, ENV105, which targets prostate […]
Pr Newswire
Precision Optics Corporation Schedules Fourth Quarter and Fiscal Year 2024 Conference Call for Monday, September 30, 2024
25
Sep
Sep
GARDNER, Mass., Sept. 24, 2024 (GLOBE NEWSWIRE) — Precision Optics Corporation, Inc. (Nasdaq: POCI) (the “Company”), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company’s fourth quarter and fiscal year 2024 financial results on Monday, September […]
25
Sep
Sep
NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) — LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will […]
25
Sep
Sep
SOUTH SAN FRANCISCO, Calif., Sept. 24, 2024 (GLOBE NEWSWIRE) — Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors or hematologic malignancies, announced today that Lynn Seely, MD, Lyell’s President & CEO, will participate on a panel discussion on next-generation cell therapies […]